Abstract Background: Tramadol is a centrally acting synthetic analgesic agent with opioid activity. Tramadol is used to treat moderate to severe pain. The entorhinal cortex has initially attracted attention because of its strong reciprocal connections with the hippocampal formation and its involvement in certain brain disorders. Aim of work: The present study was designed to assess the deleterious effects of tramadol on the entorhinal cortex of the adult male albino rats. Materials and methods: The study was carried out on 40 adult male rats. The rats were divided equally into two groups: control group, received 1 ml normal saline 0.9% intraperitoneally for 4 weeks. Treated group received 50 mg/kg/day of tramadol intraperitoneally for 4 weeks. All animals were anaesthetized by ether inhalation and perfused by normal saline. The brains were extracted from the skulls. For light microscopy, the brains of 10 animals in each group were processed for paraffin sections and stained by Gallocyanine stain. For electron microscopy, the entorhinal cortex was dissected in 10 brains of each group and processed. Semithin sections were prepared and stained with toluidine blue. Morphometric and statistical studies were performed. Results: By light microscopy, the treated groups showed neuronal cells disorganization. Apoptotic cells were detected. In addition, diffuse chromatolysis of nuclear chromatin, absence of nucleoli, multinuclear cells, intercellular edema and a congested blood capillary were noticed. By electron microscopy, the treated groups of both lateral and medial entorhinal areas showed granular and pyramidal apoptotic cells. The morphometric and statistical studies showed significant increase of apoptotic index % in treated group as compared with control group. Conclusion: Tramadol had degenerative effects on both lateral and medial entorhinal areas. Light as well as electron microscopic examination of entorhinal areas came to prove these effects. Tramadol abuse should be avoided without medical description due to its toxic effects. 
Introduction
Tramadol is listed in many medical guidelines for pain treatment and the WHO guidelines for cancer pain relief mentioned it as a step-2 analgesic. 1 In chronic non-cancer pain, tramadol may be appropriate when non-opioid analgesics are ineffective or contraindicated. Tramadol is used to treat different degrees of pain ranging from moderate to severe pain. [2] [3] [4] Tramadol is a centrally acting synthetic analgesic agent with opioid activity. It is known to provide pain relief by means of its primary metabolite, O-desmethyltramadol. 5, 6 Its withdrawal reactions include restlessness, agitation, anxiety, sweating, insomnia, hyperkinesia, tremor, paresthesias and gastrointestinal symptoms; similar to opioid withdrawal symptoms. 7, 8 Sustained-release preparations show a better tolerability profile. 3 Compared to the classical opioid analgesic morphine, tramadol is considered to be a relatively safe analgesic. Few cases of fatal poisoning due to tramadol alone have been reported in the literature. [9] [10] [11] More frequent are intoxications with coingestion of other drugs or alcohol. 12, 13 Symptoms following tramadol intoxication are similar to those of other opioids analgesics. These include central nervous system depression, coma, nausea and vomiting, tachycardia, cardiovascular collapse, seizures and respiratory depression up to respiratory arrest. Moreover, in combination with serotonergic agents (in particular, selective serotonin reuptake inhibitors and monoamine oxidase inhibitors) tramadol may induce the serotonin syndrome. [14] [15] [16] Animal studies did not reveal a carcinogenic effect of tramadol. In addition, mutagenicity studies did not show evidence of a genotoxic risk to human. Studies on the sub-acute and chronic toxicity of tramadol have been carried out in rats, dogs and rabbits. Tramadol was administered orally, subcutaneously, intravenously, intramuscularly and rectally. 17 The entorhinal cortex (EC) (ento = interior, rhino = nose, entorhinal = interior to the rhinal sulcus) is part of the medial temporal lobe or hippocampal memory system and constitutes the major gateway between the hippocampal formation and the neocortex. The entorhinal cortex has initially attracted attention because of its strong reciprocal connections with the hippocampal formation and its involvement in certain brain disorders. 18 It is divided into medial and lateral regions. Neurons in the entorhinal cortex are grouped into different layers that are characterized by a dominant cell type. Six layers are commonly distinguished, of which layers I and IV (lamina dissecans) are relatively free of neurons. The principal neurons of the entorhinal cortex, i.e., the neurons that are among the main recipients of incoming axons and constitute the major source of entorhinal output to a variety of cortical and subcortical structures, are generally pyramidal cells or modified versions, the socalled stellate cells. 19, 20 Severe alteration of the entorhinal cortex is associated with several disorders of the human brain, importantly Alzheimer's disease, temporal lobe epilepsy and schizophrenia. 21, 22 Entorhinal atrophy is associated with mild memory loss as seen in individuals with mild cognitive impairment. Temporal lobe epilepsy is associated with marked degeneration in layer III of entorhinal cortex. 23, 24 So, this study aimed to assess the deleterious effects of tramadol on the entorhinal cortex of the adult male albino rats using histological and morphometric study.
Materials and methods

Drug
Tramal [Tramadol HCl, 50 mg capsules, Mina-Pharm, Egypt] was obtained from Pharmacology department, Faculty of Medicine, Assiut University. Tramadol hydrochloride is an odorless, white to off-white crystalline powder that is readily soluble in both water and ethanol.
Experimental animals
The study was carried out on 40 adult male Sprague-Dawley rats, weighing on average 180-200 g. These animals were housed in the animal house of Assiut University in cages containing bedding of fine wood which was changed twice weekly. They were maintained under light dark cycle (12/12) hours, at a (25 ± 5)°C. All rats were fed standard rat chow before starting the experiment. The standard rat chow diet (AIN-93M diet formulated for adult rodents) was prepared according to the National Research Council (NRC) 1978. 25 This experiment was complied with the known guidelines of animal ethics committee, which were established in accordance with the internationally accepted principles for laboratory animal use and care.
Experimental protocol
The rats were randomly divided equally into two groups:
Control group I (GI): It included 20 adult male rats, the animals of this group received 1 ml normal saline 0.9% intraperitoneally for 4 weeks.
Treated group II (GII): It included 20 rats, each animal received 50 mg/kg/day of tramadol intraperitoneally for 4 weeks. 17 To prepare solution of the drug, 200 mg was dissolved in 20 ml of distilled water. Thus every 1 ml of the solution contained 10 mg of the drug. The animals were weighted and received the calculated dose of the drug according to their weight.
Histological study
All animals were anaesthetized by ether inhalation and perfused by normal saline. The brains were extracted from the skulls. For light microscopic study, the brains of 10 animals in each group were fixed in 10% formalin for 48 h. Tissues were dehydrated in ascending concentrations of alcohol, cleared in xylene and embedded in paraffin. Serial coronal sections, 5 lm in thickness were prepared and subjected to be studied by Einarson's Gallocyanin stain to demonstrate nuclei and nucleoli. 26 For electron microscopic study, the entorhinal cortex was dissected in 10 brains of each group. Tissues were fixed in phosphate buffered glutaraldehyde for 24 h and post fixed in 1% osmium tetroxide for one hour. Semithin sections (1 lm) were prepared and stained with toluidine blue. Ultrathin sections of 50 nm were cut by an ultra-microtome from selected areas, were contrasted with uranyl acetate and lead citrate 27 and were photographed with transmission electron microscope (Joel-JEM-100 CXII; Joel, Tokyo, Japan) in Assiut University Electron Microscopic Unit.
Morphometric study
Morphometric study was performed to determine the apoptotic index (AI)% of control and treated groups. The apoptotic index (AI)% was determined by counting a total of at least 1000 cells in layers II and III of entorhinal cortex per slide stained by toluidine blue. 10 non overlapping high-power fields (Â400) were chosen randomly from each slide. AI% = [number of apoptotic cells/total number of calculated cells] Â 100, is the percentage of apoptotic cells in 1000 cells. 28 Morphometric data were collected by using computer-based image analysis software (soft imaging system-An OPTIMAS version 6.2.1 program -Adept turnkey, Sydney, Australia).
Statistical study
All data were expressed as mean ± standard deviation (SD). Statistical analysis was carried out using (Graph Pad Software program -San Diego, California, USA). A Student's t-test was carried out for intergroup comparisons. P > 0.05, P 6 0.05 and P 6 0.001 were considered non-significant, significant and highly significant respectively.
Results
Histological results
3.1.1. Light microscopic results 3.1.1.1. Control group. The rat entorhinal cortex occupied the ventral-caudal part of the cerebral hemisphere and was bordered medially by the parasubiculum and laterally by the perirhinal cortex. Two main subdivisions of the entorhinal cortex were detected: lateral and medial entorhinal areas (Fig. 1) .
In the control group, the structure of both lateral and medial entorhinal areas was found to be formed of the following layers; Layer I is poorly cellular (Figs. 2a, 2b 3.1.1.2. Treated group. In the group of rats treated with tramadol, lateral entorhinal area showed neuronal cells disorganization in layers I, II, III, IV, V and VI (Fig. 2e ). Degenerative vacuolization, intercellular edema, apoptotic cells characterized by neuronal shrinkage and chromatin condensation; margination and clumping, diffuse chromatolysis of nuclear chromatin and absence of nucleoli were detected in layers I, II, III, IV, V and VI (Figs. 2f, 2g, 2h, 4c and 4d). Multinuclear cells were present in layers IV (Fig. 2g) . A dilated congested blood capillary was noticed in layer III (Fig. 2g) . Absence of the nuclei was noticed in some neurons in layers II and III ( Fig. 4c and 4d ). In addition, dark neurons with hyperbasophilia were observed in layers I, II and III ( Fig. 4c and 4d) .
The degenerative changes observed in medial entorhinal area were more or less similar to those observed in lateral Plate 4 Photomicrographs of a coronal section in the medial entorhinal area of treated group (Figs. 3e, 3f, 3g and 3h ). entorhinal area. Layers I, II, III, IV, V and VI were characterized by neuronal cells disorganization (Fig. 3e) . Intercellular edema, apoptotic cells characterized by neuronal shrinkage and chromatin condensation; margination and clumping, degenerative vacuolization, some cells with diffuse chromatolysis of nuclear chromatin and absence of nucleoli were detected in layers I, II, III, IV, V and VI (Figs. 3f, 3g, 3h, 4g and 4h). Some neurons presented with absence of their nuclei (Figs. 4g and 4h ).
3.1.2. Electron microscopic results 3.1.2.1. Control group. Electron microscopic examination of the granular cells of layer II in lateral entorhinal area revealed that the cells had rounded nuclei with fine granular chromatin. Their cytoplasm contained rough endoplasmic reticulum cisternae, numerous mitochondria and lysosomes. Nerve fibers surrounded with myelin sheaths were present (Fig. 5a) .
The pyramidal cells of layer III in the lateral entorhinal area had oval nuclei with electron dense heterochromatin. Their cytoplasm contained abundant amount of rough endoplasmic reticulum cisternae, mitochondria, numerous free ribosomes, lysosomes and few vacuoles (Fig. 5b) .
Electron microscopic examination of medial entorhinal area revealed the presence of two types of cells. The granular cells of layer II had rounded nuclei with electron dense heterochromatin. Their cytoplasm showed rough endoplasmic reticulum, mitochondria and lysosomes. Nerve fibers surrounded with myelin sheaths could be observed (Fig. 5e ). Pyramidal cells of layer III had oval nuclei with fine granular chromatin. Their cytoplasm was rich with rough endoplasmic reticulum, mitochondria and free ribosomes. Nerve fibers surrounded with myelin sheaths were noticed (Fig. 5f ).
Treated group.
In treated rats, the granular apoptotic cells in the lateral entorhinal area showed shrinkage rounded nuclei and chromatin condensation; margination and clumping with extensive electron dense heterochromatin. Their cytoplasm contained free ribosomes, distorted rough endoplasmic reticulum, many degenerative vacuoles and lysosomes. In addition, disorganized mitochondria were observed (Fig. 5c) .
The pyramidal apoptotic cells in the lateral entorhinal area showed oval nuclei, chromatin condensation; margination and Plate 7 Electron micrographs of lateral entorhinal area of control group (Figs. 5a and 5b) and treated group (Figs. 5c and 5d ). clumping, with electron dense heterochromatin. Irregularity of nuclear envelope could be observed. Their cytoplasm had many degenerative vacuoles, lysosomes and free ribosomes. Mitochondria swollen and distorted rough endoplasmic reticulum were present (Fig. 5d) .
Electron microscopic examination of medial entorhinal area showed obvious degenerative changes. The granular apoptotic cells had shrinkage rounded nuclei, chromatin condensation; margination, and clumping with electron dense heterochromatin and irregularity of nuclear envelope. Many degenerative vacuoles, lysosomes, free ribosomes, mitochondria swollen and distorted rough endoplasmic reticulum were present in the cytoplasm (Fig. 5g) .
The pyramidal apoptotic cells had shrinkage oval nuclei, chromatin condensation; margination, and clumping, with electron dense heterochromatin and irregularity of nuclear envelope. Many degenerative vacuoles, lysosomes, free ribosomes, damaged mitochondria and distorted rough endoplasmic reticulum could be detected in the cytoplasm (Fig. 5h). 
Morphometric and statistical results
The mean value ± SD (standard deviation) of the apoptotic index% in the treated group (GII) was 2.63 ± 26.08 which showed high significant increase (P 6 0.001) as compared to the control group (GI) where the apoptotic index % was 0.97 ± 1.20 (Table 1 and Histogram 1).
Plate 8 Electron micrographs of medial entorhinal area of control group (Figs. 5e and 5f) and treated group (Figs. 5g and 5h ). 
Discussion
The current study aimed to assess the deleterious effects of tramadol on the entorhinal cortex of the adult male albino rats. Tramadol belongs to the synthetic opioid analgesic that is commonly prescribed for moderate to severe pain. It has been called an ''atypical" opioid because both an opioid component and a nonopioid component have been demonstrated in its mechanism of action. 29 The brain is particularly susceptible to oxidative damage due to its high levels of oxygen consumption, increased levels of polyunsaturated fatty acids and relatively low levels of antioxidants. 30 The present study revealed that tramadol resulted in obvious degenerative changes in both lateral and medial entorhinal areas. These observations were in agreement with the results of the previous studies that reported the oxidative stress induced by the tramadol in brain. [31] [32] [33] [34] The tramadol not only induced oxidative stress in brain but also was associated with significant decrease in brain non-enzymatic antioxidant, intracellular reduced glutathione level and enzymatic antioxidant and glutathione peroxidase activity. 35 Moreover, it has been reported that oxidative modifications resulted in a loss of function and lowering of enzyme activity. 36 In addition a long-term effect of tramadol on neuronal glucose metabolism and insulin signaling pathway in the cerebral cortex consequently leads to development of oxidative stress. 37 In this study, light microscopic examination of the lateral and medial entorhinal areas showed neuronal cells disorganization, intercellular edema, apoptotic cells characterized by neuronal shrinkage and chromatin condensation, degenerative vacuolization and dark neurons with hyperbasophilia. Dilated congested blood vessels were also detected. In harmony with the present results some investigators reported the presence of congested sub meningeal blood vessels and neuronal degeneration following tramadol administration. 38 These findings coincided with Liu et al. 39 . They stated that the multiple effects of opioids on neuronal structure (cytoskeleton) have been regarded as the markers of neuronal damage due to long term use of morphine and other opioids. They also found that the apoptotic cells were present with cytoplasmic contraction, reduction in cell volume and nuclear chromatin condensation.
In this work, electron microscopic examination revealed the presence of apoptotic pyramidal and granular cells in both lateral and medial entorhinal areas. These apoptotic cells showed shrinkage of nuclei, irregularity of the nuclear envelope, chromatin condensation, mitochondria swollen, degenerative vacuolation and distorted rough endoplasmic reticulum. These histological findings were confirmed by the morphometric and statistical results as apoptotic index showed high significant increase in the treated group in comparison with the control group. Mohamed et al. 40 noticed that tramadol administration resulted in loss of pyramidal cells shape, perivascular space increased with hemorrhage, and disrupted ependyma and choroid plexus became hypertrophied. The chronic use of morphine and/or tramadol in increasing doses was found to cause neuronal degeneration and apoptosis in the rat brain, which probably contributed to cerebral dysfunction. 41 In the present study, the degenerative vacuolation could be attributed to the damaged cell organoid from exposure to free radicals. 42, 43 The observed mitochondrial changes might be considered as early manifestation of apoptosis and an adaptive process to unfavorable environments as excess exposure of the cell to free radicals at the level of intracellular organelles. These suggestions might be confirmed by the successful suppression of these changes by free radical scavengers. 44 It has been reported that Complexes I, III, and IV of electron transfer chain (ETC) in mitochondria were found to be inhibited by tramadol at high doses. Inhibition of complex III resulted in the generation of reactive oxygen species as a consequence of the intrinsic characteristics of the electron transfer process to this complex from reduced ubiquinone. 40, 45 The toxic effects of tramadol at the cellular level could be explained by increasing lipid peroxidation that could be used as a marker of the reactive oxygen species (ROS)-induced cell damages. 32 Moreover, it has been found that lipid peroxidation was significantly increased in chronic heroin users. 46 These data were confirmed by the results of previous studies done by Zhang et al. 47 and Atici et al. 48 as they demonstrated that treatment with morphine and tramadol yielded an increased malondialdehyde (MDA) level, which suggested an increased lipid peroxidation. In addition, they observed a decrease in the level of reduced glutathione in the isolated rat hepatocytes in the case of incubation with different opioids concentration (yielding cell death) and they also noticed a lowered content of reduced glutathione and activities of catalase, superoxide dismutase and glutathione peroxidase.
Conclusion
The results of the present study provided evidence that tramadol intake exerted a neurotoxic effect on the structure of both lateral and medial entorhinal areas. So tramadol abuse should be avoided without medical description. Further investigations are needed for more comparison and interpretation.
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